Humana Inc [HUM] stock is trading at $241.96, down -0.11%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The HUM shares have gain 5.57% over the last week, with a monthly amount drifted -13.02%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Humana Inc [NYSE: HUM] stock has seen the most recent analyst activity on October 14, 2025, when Goldman initiated its Sell rating and assigned the stock a price target of $235. Previously, Evercore ISI started tracking the stock with In-line rating on September 22, 2025, and set its price target to $295. On May 01, 2025, upgrade upgraded it’s rating to Outperform but maintained its price target of $315 on the stock. BofA Securities upgraded its rating to a Neutral and increased its price target to $308 on November 06, 2024. KeyBanc Capital Markets initiated its recommendation with a Sector Weight. Bernstein upgraded its rating to Outperform for this stock on October 08, 2024, but kept the price target unchanged to $308. In a note dated October 07, 2024, TD Cowen downgraded an Hold rating on this stock and revised its target price from $402 to $261.
Humana Inc [HUM] stock has fluctuated between $206.87 and $315.35 over the past year. Currently, Wall Street analysts expect the stock to reach $289.2 within the next 12 months. Humana Inc [NYSE: HUM] shares were valued at $241.96 at the most recent close of the market. An investor can expect a potential return of 19.52% based on the average HUM price forecast.
Analyzing the HUM fundamentals
Humana Inc [NYSE:HUM] reported sales of 126.36B for the trailing twelve months, which represents a growth of 11.06%. Gross Profit Margin for this corporation currently stands at 0.23% with Operating Profit Margin at 0.02%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.07 and Total Capital is 0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.68.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 239.18 points at the first support level, and at 236.40 for the second support level. However, for the 1st resistance point, the stock is sitting at 244.37, and for the 2nd resistance point, it is at 246.78.
Ratios To Look Out For
For context, Humana Inc’s Current Ratio is 2.02. Considering the valuation of this stock, the price to sales ratio is 0.23, the price to book ratio is 1.57 and price to earnings (TTM) ratio is 22.68.
Transactions by insiders
Recent insider trading involved Rechtin James A., President & CEO, that happened on May 14 ’25 when 6530.0 shares were purchased. Former Chief Financial Officer, Diamond Susan M completed a deal on Apr 08 ’25 to buy 10959.0 shares. Meanwhile, Former Chief Administrative Of Huval Timothy S. bought 1247.0 shares on Feb 24 ’25.
